Nifty

:

25255.05

Sensex

:

81879.40

210.40 (0.84%)
772.75 (0.95%)

Login

Nifty
Sensex

:
:

25255.05
81879.40

210.40 (0.84%)
772.75 (0.95%)

RPG Life Sciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

71/99

BSE: 532983 | NSE: RPGLIFE

Watchlist

NSE BSE

2606.20

11-Nov-2026

Open
High
Low
Previous Close

2648
2648
2586.2
2596.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

6226
16228801.4
3127.8
1733

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,317.43
39.47
8

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,209.76
0.92%
6.28

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.19
9.96
6.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.85
11.17
2.77

PAT CAGR (%)

10 Years
5 Years
3 Years

25.28
17.47
9.52

P:E (Median)

8 Years
5 Years
3 Years

123.07
271.31
401.54

P:BV (Average)

8 Years
5 Years
3 Years

0.33
0.53
0.88

EV:EBITDA (Average)

8 Years
5 Years
3 Years

3.42
1.87
3.12

Earnings Forecasts:

(Updated: 07-11-2026)

Description 2026 2027 2028 2029
Adj EPS 69.64 77.1 94.2 -
P/E Ratio 37.42 33.80 27.67 -
Revenue 707.52 858.2 1004.2 -
EBITDA 147.13 191.6 248.9 -
Net Income 115.17 132.7 165.8 -
ROA 15.88 - - -
P/B Ratio 7.12 4.53 4.01 -
ROE 20.28 13.4 14.5 -
FCFF -0.08 -135.7 120.5 -
FCFF Yield 0 -3.33 2.96 -
Net Debt -220.68 - - -
BVPS 366.03 574.7 650.1 -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 193.39 181.68 6.45% 195.69 168.92 15.85% 176.89 143.09 23.62% 180.03 172.71 4.24%
Expenses 160.74 142.65 12.68% 152.11 133.45 13.98% 144.02 117.60 22.47% 140.27 123.55 13.53%
EBITDA 32.65 39.03 -16.35% 43.58 35.47 22.86% 32.87 25.49 28.95% 39.76 49.16 -19.12%
EBIDTM 16.88% 21.48% 22.27% 21.00% 18.58% 17.81% 22.09% 28.46%
Other Income 3.77 4.54 -16.96% 4.16 5.23 -20.46% 12.36 5.06 144.27% 3.41 3.31 3.02%
Interest 0.78 0.12 550.00% 0.63 0.13 384.62% 0.39 0.18 116.67% 0.25 0.12 108.33%
Depreciation 5.56 5.22 6.51% 5.90 5.14 14.79% 5.74 5.37 6.89% 5.38 5.46 -1.47%
PBT 30.08 49.45 -39.17% 41.21 35.43 16.31% 40.20 134.90 -70.20% 29.12 46.89 -37.90%
Tax 6.79 12.60 -46.11% 10.64 9.14 16.41% 10.30 17.55 -41.31% 6.99 11.96 -41.56%
PAT 23.29 36.85 -36.80% 30.57 26.29 16.28% 29.90 117.35 -74.52% 22.13 34.93 -36.64%
PATM 12.04% 20.28% 15.62% 15.56% 16.90% 82.01% 12.29% 20.22%
EPS 14.12 22.33 -36.77% 18.53 15.93 16.32% 18.12 71.12 -74.52% 13.41 21.17 -36.66%

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 211.64 181.68 16.49% 195.69 168.92 15.85% 176.89 143.09 23.62% 180.03 172.71 4.24%
Expenses 171.22 142.65 20.03% 152.40 133.45 14.20% 144.06 117.60 22.50% 140.27 123.55 13.53%
EBITDA 40.42 39.03 3.56% 43.29 35.47 22.05% 32.83 25.49 28.80% 39.76 49.16 -19.12%
EBIDTM 19.10% 21.48% 22.12% 21.00% 18.56% 17.81% 22.09% 28.46%
Other Income 4.26 4.54 -6.17% 4.70 5.23 -10.13% 12.40 5.06 145.06% 3.41 3.31 3.02%
Interest 0.84 0.12 600.00% 0.63 0.13 384.62% 0.39 0.18 116.67% 0.25 0.12 108.33%
Depreciation 6.80 5.22 30.27% 5.90 5.14 14.79% 5.74 5.37 6.89% 5.38 5.46 -1.47%
PBT 37.04 49.45 -25.10% 41.46 35.43 17.02% 40.20 134.90 -70.20% 29.12 46.89 -37.90%
Tax 8.82 12.60 -30.00% 10.70 9.14 17.07% 10.30 17.55 -41.31% 6.99 11.96 -41.56%
PAT 28.22 36.85 -23.42% 30.76 26.29 17.00% 29.90 117.35 -74.52% 22.13 34.93 -36.64%
PATM 13.33% 20.28% 15.72% 15.56% 16.90% 82.01% 12.29% 20.22%
EPS 16.08 22.28 -27.83% 18.60 15.90 16.98% 18.08 70.96 -74.52% 13.38 21.12 -36.65%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 746.00 707.52 653.43 582.05 512.81 440.16 389.14 375.57 330.16 343.95 293.64 Net Sales Growth 11.94% 8.28% 12.26% 13.50% 16.51% 13.11% 3.61% 13.75% -4.01% 17.13% Cost Of Goods Sold 263.92 233.22 196.65 167.82 156.64 127.59 121.27 119.63 103.93 106.87 96.02 Gross Profit 482.08 474.30 456.78 414.23 356.17 312.57 267.87 255.94 226.23 237.08 197.62 GP Margin 64.62% 67.04% 69.90% 71.17% 69.45% 71.01% 68.84% 68.15% 68.52% 68.93% 67.30% Total Expenditure 597.14 559.51 494.43 452.91 409.28 353.00 318.37 315.67 295.73 306.89 265.01 Power & Fuel Cost - 18.50 17.66 14.36 13.65 12.69 11.27 11.54 10.38 10.44 9.10 % Of Sales - 2.61% 2.70% 2.47% 2.66% 2.88% 2.90% 3.07% 3.14% 3.04% 3.10% Employee Cost - 141.48 126.14 132.15 117.06 99.97 94.66 90.97 89.93 90.14 75.59 % Of Sales - 20.00% 19.30% 22.70% 22.83% 22.71% 24.33% 24.22% 27.24% 26.21% 25.74% Manufacturing Exp. - 49.02 46.35 43.80 36.62 37.86 28.79 21.85 18.98 21.86 20.63 % Of Sales - 6.93% 7.09% 7.53% 7.14% 8.60% 7.40% 5.82% 5.75% 6.36% 7.03% General & Admin Exp. - 56.42 48.64 41.63 37.14 33.97 28.54 32.76 34.32 35.76 31.57 % Of Sales - 7.97% 7.44% 7.15% 7.24% 7.72% 7.33% 8.72% 10.39% 10.40% 10.75% Selling & Distn. Exp. - 42.94 46.22 37.85 35.62 32.27 25.47 20.13 18.61 22.51 17.90 % Of Sales - 6.07% 7.07% 6.50% 6.95% 7.33% 6.55% 5.36% 5.64% 6.54% 6.10% Miscellaneous Exp. - 17.93 12.77 15.30 12.55 8.65 8.37 18.79 19.58 19.31 17.90 % Of Sales - 2.53% 1.95% 2.63% 2.45% 1.97% 2.15% 5.00% 5.93% 5.61% 4.84% EBITDA 148.86 148.01 159.00 129.14 103.53 87.16 70.77 59.90 34.43 37.06 28.63 EBITDA Margin 19.95% 20.92% 24.33% 22.19% 20.19% 19.80% 18.19% 15.95% 10.43% 10.77% 9.75% Other Income 23.70 25.54 14.30 7.21 4.80 3.08 1.07 0.99 0.80 2.36 0.86 Interest 2.05 1.77 1.59 1.44 1.15 1.41 1.79 2.76 4.86 4.72 3.64 Depreciation 22.58 21.48 21.43 17.07 15.50 15.66 16.47 16.36 15.32 14.34 11.31 PBT 140.61 150.30 150.28 117.84 91.68 73.17 53.58 41.77 15.05 20.36 14.54 Tax 34.72 39.03 49.64 30.18 24.04 21.69 13.58 7.44 4.24 6.91 2.45 Tax Rate 24.69% 25.31% 21.32% 25.61% 26.22% 29.64% 25.35% 20.41% 28.17% 33.94% 16.85% PAT 105.89 115.17 183.24 87.66 67.64 51.48 40.00 29.01 10.81 13.45 12.09 PAT before Minority Interest 105.89 115.17 183.24 87.66 67.64 51.48 40.00 29.01 10.81 13.45 12.09 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.19% 16.28% 28.04% 15.06% 13.19% 11.70% 10.28% 7.72% 3.27% 3.91% 4.12% PAT Growth -50.84% -37.15% 109.03% 29.60% 31.39% 28.70% 37.88% 168.36% -19.63% 11.25% EPS 64.18 69.80 111.05 53.13 40.99 31.20 24.24 17.58 6.55 8.15 7.33

Description TTM Mar 26 Mar 25
Net Sales 764.25 707.52 653.43 Net Sales Growth 14.68% 8.28% Cost Of Goods Sold 265.78 233.22 196.65 Gross Profit 498.47 474.30 456.78 GP Margin 65.22% 67.04% 69.90% Total Expenditure 607.95 559.55 494.46 Power & Fuel Cost - 18.50 17.66 % Of Sales - 2.61% 2.70% Employee Cost - 141.48 126.14 % Of Sales - 20.00% 19.30% Manufacturing Exp. - 49.02 46.35 % Of Sales - 6.93% 7.09% General & Admin Exp. - 56.52 48.64 % Of Sales - 7.99% 7.44% Selling & Distn. Exp. - 42.94 46.22 % Of Sales - 6.07% 7.07% Miscellaneous Exp. - 17.87 12.80 % Of Sales - 2.53% 1.96% EBITDA 156.30 147.97 158.97 EBITDA Margin 20.45% 20.91% 24.33% Other Income 24.77 25.58 14.33 Interest 2.11 1.77 1.59 Depreciation 23.82 21.48 21.43 PBT 147.82 150.30 150.28 Tax 36.81 39.03 49.64 Tax Rate 24.90% 25.31% 21.32% PAT 111.01 115.17 183.24 PAT before Minority Interest 109.39 115.17 183.24 Minority Interest -1.62 0.00 0.00 PAT Margin 14.53% 16.28% 28.04% PAT Growth -48.47% -37.15% EPS 67.28 69.80 111.05

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 605.37 530.53 374.85 307.60 255.77 216.45 176.57 160.50 154.75 147.01 Share Capital 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 Total Reserves 592.14 517.30 361.62 294.37 242.54 203.22 163.34 147.27 141.52 133.78 Non-Current Liabilities 27.24 6.45 6.48 8.97 8.73 7.19 8.75 9.58 8.37 10.77 Secured Loans 13.33 0.00 0.00 0.00 0.01 0.08 0.22 4.63 10.11 15.89 Unsecured Loans 0.00 0.00 0.00 0.00 0.29 0.66 1.30 1.95 0.12 0.16 Long Term Provisions 7.41 4.54 4.03 3.98 3.04 3.13 8.50 6.19 2.79 2.32 Current Liabilities 160.53 119.83 130.96 102.78 80.11 79.69 82.59 77.82 120.71 78.68 Trade Payables 97.21 79.39 71.02 64.69 45.50 47.44 44.41 25.13 51.87 28.65 Other Current Liabilities 32.97 24.33 45.05 26.23 19.87 18.12 20.30 13.32 18.47 14.91 Short Term Borrowings 0.00 0.00 0.00 0.00 0.21 0.52 5.12 29.04 37.92 24.01 Short Term Provisions 30.35 16.11 14.89 11.86 14.53 13.61 12.76 10.33 12.45 11.11 Total Liabilities 793.14 656.81 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46 Net Block 196.54 171.83 113.53 124.26 103.71 113.30 122.89 127.64 130.80 136.67 Gross Block 321.10 276.05 221.52 220.01 186.37 180.44 173.81 162.55 150.65 142.43 Accumulated Depreciation 124.56 104.22 107.99 95.75 82.66 67.14 50.92 34.91 19.85 5.76 Non Current Assets 268.45 191.56 214.20 155.30 137.70 127.48 142.13 150.81 141.21 140.08 Capital Work in Progress 23.29 16.06 96.31 25.44 31.06 11.77 9.98 17.17 8.73 1.82 Non Current Investment 35.79 1.01 1.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 12.83 2.66 3.35 5.60 2.93 2.41 9.26 6.00 1.68 1.59 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 524.69 465.25 298.09 264.05 206.91 175.85 125.78 97.09 142.62 96.38 Current Investments 83.90 125.90 90.15 58.43 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 123.84 92.98 101.00 95.05 82.99 58.33 46.61 41.04 53.69 45.78 Sundry Debtors 116.68 86.76 49.13 37.43 32.99 57.42 63.33 38.90 68.13 39.28 Cash & Bank 156.78 139.61 36.47 57.04 70.26 40.75 1.11 0.77 0.94 1.60 Other Current Assets 43.49 10.11 4.86 5.41 20.67 19.35 14.73 16.38 19.86 9.72 Short Term Loans & Adv. 27.92 9.89 16.48 10.69 14.03 10.64 6.51 9.45 12.26 4.13 Net Current Assets 364.16 345.42 167.13 161.27 126.80 96.16 43.19 19.27 21.91 17.70 Total Assets 793.14 656.81 512.29 419.35 344.61 303.33 267.91 247.90 283.83 236.46

Description Mar 26 Mar 25
Shareholder's Funds 605.35 530.53 Share Capital 13.23 13.23 Total Reserves 592.12 517.30 Non-Current Liabilities 27.24 6.45 Secured Loans 13.33 0.00 Unsecured Loans 0.00 0.00 Long Term Provisions 7.41 4.54 Current Liabilities 160.57 119.83 Trade Payables 97.25 79.39 Other Current Liabilities 32.97 24.33 Short Term Borrowings 0.00 0.00 Short Term Provisions 30.35 16.11 Total Liabilities 793.16 656.81 Net Block 196.54 171.83 Gross Block 321.10 276.05 Accumulated Depreciation 124.56 104.22 Non Current Assets 233.68 191.56 Capital Work in Progress 23.29 16.06 Non Current Investment 1.01 1.01 Long Term Loans & Adv. 12.84 2.66 Other Non Current Assets 0.00 0.00 Current Assets 559.48 465.25 Current Investments 83.90 125.90 Inventories 123.84 92.98 Sundry Debtors 116.68 86.76 Cash & Bank 191.56 139.61 Other Current Assets 43.50 10.11 Short Term Loans & Adv. 27.92 9.89 Net Current Assets 398.91 345.42 Total Assets 793.16 656.81

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 56.50 77.86 94.36 90.82 64.75 58.27 50.17 45.78 14.68 7.33 PBT 154.20 232.88 117.84 91.68 73.17 53.58 36.45 15.05 20.36 23.46 Adjustment -17.31 -76.22 12.92 13.31 13.54 16.55 22.52 20.08 17.37 6.95 Changes in Working Capital -43.18 -26.05 -7.09 11.06 -3.11 -3.53 -2.37 14.37 -19.35 -18.81 Cash after chg. in Working capital 93.71 130.61 123.67 116.05 83.60 66.60 56.60 49.50 18.38 11.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -37.21 -52.75 -29.31 -25.23 -18.85 -8.33 -6.43 -3.72 -3.70 -4.27 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 51.06 -41.80 -79.15 -105.81 -34.66 -7.96 -10.70 -19.02 -15.54 -30.06 Net Fixed Assets -52.28 25.72 -72.38 -28.02 -25.22 -8.42 -4.07 -20.34 -15.13 47.17 Net Investments 7.22 -35.75 -32.73 -58.43 0.00 0.00 0.00 0.00 0.00 0.00 Others 96.12 -31.77 25.96 -19.36 -9.44 0.46 -6.63 1.32 -0.41 -77.23 Cash from Financing Activity -20.58 -27.08 -20.31 -17.12 -13.51 -10.49 -39.30 -26.50 0.11 23.36 Net Cash Inflow / Outflow 86.98 8.98 -5.10 -32.11 16.58 39.82 0.17 0.26 -0.75 0.63 Opening Cash & Equivalents 28.70 19.72 24.82 56.93 40.36 0.54 0.37 0.11 0.86 0.23 Closing Cash & Equivalent 115.68 28.70 19.72 24.82 56.94 40.36 0.54 0.37 0.11 0.86

Description Mar 26 Mar 25
Cash From Operating Activity 56.50 77.86 PBT 154.20 232.88 Adjustment -17.31 -76.22 Changes in Working Capital -43.17 -26.05 Cash after chg. in Working capital 93.72 130.61 Interest Paid 0.00 0.00 Tax Paid -37.22 -52.75 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity 85.84 -41.80 Net Fixed Assets -52.28 Net Investments 7.22 Others 130.90 Cash from Financing Activity -20.58 -27.08 Net Cash Inflow / Outflow 121.76 8.98 Opening Cash & Equivalents 28.70 19.72 Closing Cash & Equivalent 150.46 28.70

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 366.06 320.80 226.67 186.00 154.66 130.88 106.77 97.05 93.58 88.89 ROA 15.89% 31.35% 18.82% 17.71% 15.89% 14.00% 11.25% 4.07% 5.17% 9.15% ROE 20.28% 40.48% 25.69% 24.01% 21.80% 20.36% 17.21% 6.86% 8.91% 14.98% ROCE 26.99% 51.79% 34.96% 32.92% 31.46% 27.27% 20.35% 9.81% 12.52% 15.58% Fixed Asset Turnover 2.53 2.82 2.83 2.73 2.61 2.37 2.23 2.11 2.37 1.85 Receivable days 49.08 35.40 25.32 23.17 34.41 52.52 49.68 59.16 56.47 45.37 Inventory Days 52.31 50.53 57.35 58.57 53.79 45.64 42.59 52.36 52.29 50.44 Payable days 138.19 139.59 147.58 128.38 132.94 138.23 44.01 56.38 53.51 47.24 Cash Conversion Cycle -36.81 -53.67 -64.92 -46.65 -44.74 -40.07 48.25 55.15 55.25 48.57 Total Debt/Equity 0.03 0.00 0.00 0.00 0.00 0.01 0.07 0.23 0.35 0.30 Interest Cover 88.12 147.47 82.83 80.72 52.89 30.93 14.21 4.10 5.31 7.45

Description Mar 26 Mar 25
Book Value (Rs.) 366.05 320.80 ROA 15.89% 27.90% ROE 20.28% 34.54% ROCE 26.99% 44.20% Fixed Asset Turnover 2.53 2.54 Receivable days 49.08 45.20 Inventory Days 52.31 48.44 Payable days 138.22 147.35 Cash Conversion Cycle -36.84 -53.72 Total Debt/Equity 0.03 0.00 Interest Cover 88.12 147.47

Top Investors:

clarus capital i

authum investment and infrastructure limited

investor education and protection fund authority ministry of corporate affairs

Annual Reports:

News Update:

RPG Life Sciences’ arm to acquire API business of Raghava Life Sciences
3rd Sep 2026, 11:39 AM

The acquisition is the next step in RPGAP's consolidation play based on a well-planned buy-and-build strategy to bolster organic growth and create an integrated, scaled API focused organization
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback